A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 15 shares of CYTK stock, worth $837. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 8 87.5%
Holding current value
$837
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$51.22 - $60.16 $358 - $421
7 Added 87.5%
15 $0
Q2 2024

Jul 30, 2024

BUY
$47.86 - $75.05 $382 - $600
8 New
8 $0

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $5.26B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Di Nuzzo Private Wealth, Inc. Portfolio

Follow Di Nuzzo Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Di Nuzzo Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Di Nuzzo Private Wealth, Inc. with notifications on news.